Kennedy Capital Management LLC Reduces Position in Chemed Co. (NYSE:CHE)

Kennedy Capital Management LLC reduced its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 2.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,723 shares of the company's stock after selling 542 shares during the period. Kennedy Capital Management LLC owned 0.16% of Chemed worth $13,098,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in CHE. UMB Bank n.a. grew its holdings in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after buying an additional 39 shares in the last quarter. Atala Financial Inc purchased a new position in Chemed during the fourth quarter worth about $29,000. CBIZ Investment Advisory Services LLC boosted its holdings in Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the last quarter. Trust Co. of Vermont acquired a new stake in shares of Chemed during the 4th quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC lifted its holdings in Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after acquiring an additional 34 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This represents a 1.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 3.32% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CHE. Royal Bank of Canada upped their price target on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research note on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Price Performance

Shares of CHE stock traded down $8.03 on Tuesday, hitting $592.66. The stock had a trading volume of 55,559 shares, compared to its average volume of 97,105. The company's 50 day moving average price is $583.92 and its 200-day moving average price is $567.73. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $625.09. The firm has a market capitalization of $8.66 billion, a P/E ratio of 29.95, a P/E/G ratio of 2.15 and a beta of 0.49.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed's dividend payout ratio (DPR) is 10.05%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.